These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 29813042)
1. Proteflazid®: treatment of herpesvirus and mixed infections. Meta-analysis of clinical trials results. Matyash V; Grynevych O; Broun T Pol Merkur Lekarski; 2018 May; 44(263):236-247. PubMed ID: 29813042 [TBL] [Abstract][Full Text] [Related]
2. Proteflazid® and local immunity in diseases caused by human papillomavirus, herpesvirus and mixed urogenital infections. Kaminsky V; Chernyshov V; Grynevych O; Benyuk V; Kornatskaya A; Shalko M; Usevich I; Revenko O; Shepetko M; Solomakha L Pol Merkur Lekarski; 2017 Mar; 42(249):110-115. PubMed ID: 28333902 [TBL] [Abstract][Full Text] [Related]
3. Proteflazid®: outcome analysis of clinical trials studying the impact of human herpesvirus infection on some cellular immunity indicators and gestation course in women. Benyuk V; Kuznetsova L; Grynevych O; Broun T; Momotiuk L; Motuzka O; Yashchenko L Pol Merkur Lekarski; 2019 Apr; 46(274):157-164. PubMed ID: 31099761 [TBL] [Abstract][Full Text] [Related]
4. Proteflazid® effectiveness for prevention and treatment of acute viral respiratory infections in the conditions of COVID-19. Grynevych O; Borshov S; Matyash V; Momotiuk L; Motuzka O; Yashchenko L Pol Merkur Lekarski; 2021 Aug; 49(292):255-265. PubMed ID: 34464364 [TBL] [Abstract][Full Text] [Related]
5. Antiviral effect of aqueous extracts from species of the Lamiaceae family against Herpes simplex virus type 1 and type 2 in vitro. Nolkemper S; Reichling J; Stintzing FC; Carle R; Schnitzler P Planta Med; 2006 Dec; 72(15):1378-82. PubMed ID: 17091431 [TBL] [Abstract][Full Text] [Related]
6. Topical cream-based oxyresveratrol in the treatment of cutaneous HSV-1 infection in mice. Lipipun V; Sasivimolphan P; Yoshida Y; Daikoku T; Sritularak B; Ritthidej G; Likhitwitayawuid K; Pramyothin P; Hattori M; Shiraki K Antiviral Res; 2011 Aug; 91(2):154-60. PubMed ID: 21669230 [TBL] [Abstract][Full Text] [Related]
7. Genital herpes. Garland SM; Steben M Best Pract Res Clin Obstet Gynaecol; 2014 Oct; 28(7):1098-110. PubMed ID: 25153069 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of herpes simplex type 1 and type 2 infections by Oximacro(®), a cranberry extract with a high content of A-type proanthocyanidins (PACs-A). Terlizzi ME; Occhipinti A; Luganini A; Maffei ME; Gribaudo G Antiviral Res; 2016 Aug; 132():154-64. PubMed ID: 27321663 [TBL] [Abstract][Full Text] [Related]
9. HSV antivirals - current and future treatment options. Birkmann A; Zimmermann H Curr Opin Virol; 2016 Jun; 18():9-13. PubMed ID: 26897058 [TBL] [Abstract][Full Text] [Related]
10. Novel therapeutic investigational strategies to treat severe and disseminated HSV infections suggested by a deeper understanding of in vitro virus entry processes. Clementi N; Criscuolo E; Cappelletti F; Burioni R; Clementi M; Mancini N Drug Discov Today; 2016 Apr; 21(4):682-91. PubMed ID: 26976690 [TBL] [Abstract][Full Text] [Related]
11. Chemical properties, mode of action, and in vivo anti-herpes activities of a lignin-carbohydrate complex from Prunella vulgaris. Zhang Y; But PP; Ooi VE; Xu HX; Delaney GD; Lee SH; Lee SF Antiviral Res; 2007 Sep; 75(3):242-9. PubMed ID: 17475343 [TBL] [Abstract][Full Text] [Related]
12. Proteflazid®: Clinical experience in children of young and preschool age - systematic review of postmarketing surveillance. Beketova G; Grynevych O; Solomakha L; Golovnia N Pol Merkur Lekarski; 2018 Feb; 44(260):75-81. PubMed ID: 29498372 [TBL] [Abstract][Full Text] [Related]
13. [Mother-infant and indirect transmission of HSV infection: treatment and prevention]. Henrot A Ann Dermatol Venereol; 2002 Apr; 129(4 Pt 2):533-49. PubMed ID: 12122323 [TBL] [Abstract][Full Text] [Related]
14. Virucidal effect of peppermint oil on the enveloped viruses herpes simplex virus type 1 and type 2 in vitro. Schuhmacher A; Reichling J; Schnitzler P Phytomedicine; 2003; 10(6-7):504-10. PubMed ID: 13678235 [TBL] [Abstract][Full Text] [Related]
15. Proanthocyanidin-enriched extract from Myrothamnus flabellifolia Welw. exerts antiviral activity against herpes simplex virus type 1 by inhibition of viral adsorption and penetration. Gescher K; Kühn J; Lorentzen E; Hafezi W; Derksen A; Deters A; Hensel A J Ethnopharmacol; 2011 Mar; 134(2):468-74. PubMed ID: 21211557 [TBL] [Abstract][Full Text] [Related]
17. The AGMA1 poly(amidoamine) inhibits the infectivity of herpes simplex virus in cell lines, in human cervicovaginal histocultures, and in vaginally infected mice. Donalisio M; Quaranta P; Chiuppesi F; Pistello M; Cagno V; Cavalli R; Volante M; Bugatti A; Rusnati M; Ranucci E; Ferruti P; Lembo D Biomaterials; 2016 Apr; 85():40-53. PubMed ID: 26854390 [TBL] [Abstract][Full Text] [Related]
18. Prevention, recognition and management of neonatal HSV infections. Robinson JL; Vaudry WL; Forgie SE; Lee BE Expert Rev Anti Infect Ther; 2012 Jun; 10(6):675-85. PubMed ID: 22734957 [TBL] [Abstract][Full Text] [Related]
19. Valacyclovir for herpes simplex virus infection: long-term safety and sustained efficacy after 20 years' experience with acyclovir. Tyring SK; Baker D; Snowden W J Infect Dis; 2002 Oct; 186 Suppl 1():S40-6. PubMed ID: 12353186 [TBL] [Abstract][Full Text] [Related]
20. 2017 European guidelines for the management of genital herpes. Patel R; Kennedy OJ; Clarke E; Geretti A; Nilsen A; Lautenschlager S; Green J; Donders G; van der Meijden W; Gomberg M; Moi H; Foley E Int J STD AIDS; 2017 Dec; 28(14):1366-1379. PubMed ID: 28836892 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]